Russell Investments Group’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.6K | Sell |
10,782
-28,116
| -72% | -$142K | ﹤0.01% | 2965 |
|
|
2025
Q1 | $206K | Sell |
38,898
-157,754
| -80% | -$835K | ﹤0.01% | 2586 |
|
|
2024
Q4 | $1.33M | Sell |
196,652
-41,446
| -17% | -$280K | ﹤0.01% | 1865 |
|
|
2024
Q3 | $1.57M | Buy |
238,098
+89,335
| +60% | +$589K | ﹤0.01% | 1810 |
|
|
2024
Q2 | $1.12M | Sell |
148,763
-9,542
| -6% | -$71.6K | ﹤0.01% | 1924 |
|
|
2024
Q1 | $1.58M | Buy |
158,305
+49,292
| +45% | +$491K | ﹤0.01% | 1770 |
|
|
2023
Q4 | $1.07M | Sell |
109,013
-21,888
| -17% | -$216K | ﹤0.01% | 1933 |
|
|
2023
Q3 | $1M | Buy |
130,901
+55,600
| +74% | +$425K | ﹤0.01% | 1927 |
|
|
2023
Q2 | $562K | Sell |
75,301
-56,655
| -43% | -$423K | ﹤0.01% | 2184 |
|
|
2023
Q1 | $880K | Hold |
131,956
| – | – | ﹤0.01% | 2039 |
|
|
2022
Q4 | $1.02M | Sell |
131,956
-3,117
| -2% | -$24K | ﹤0.01% | 1965 |
|
|
2022
Q3 | $1.44M | Buy |
135,073
+6,536
| +5% | +$69.4K | ﹤0.01% | 1748 |
|
|
2022
Q2 | $1.05M | Buy |
+128,537
| New | +$1.05M | ﹤0.01% | 1943 |
|
|
2022
Q1 | – | Sell |
-34,166
| Closed | -$584K | – | 2902 |
|
|
2021
Q4 | $584K | Buy |
34,166
+2,633
| +8% | +$45K | ﹤0.01% | 2387 |
|
|
2021
Q3 | $725K | Hold |
31,533
| – | – | ﹤0.01% | 2332 |
|
|
2021
Q2 | $1.15M | Buy |
+31,533
| New | +$1.15M | ﹤0.01% | 2244 |
|